Late response to allergen is associated with increased concentrations of tumor necrosis factor-α and IL-5 in induced sputum

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 5, 1997, Pages 693-698

  Keatings, Vera M ^a   O'Connor, Brian J ^a   Wright, Lyndon G ^a   Huston, David P ^b   Corrigan, Christopher J ^c   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

allergen; asthma; Bronchial provocation test; eosinophils; GM CSF; IL 5; induced sputum; interleukin; TNF

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; PRIORITY JOURNAL; PROVOCATION TEST; SPIROMETRY; SPUTUM ANALYSIS;

EID: 0030919101     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70032-0     Document Type: Article

References (21)

1. Rossi G, Crimi E, Lantero S, et al. Late phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils into the airways. Am Rev Respir Dis 1991;144:379-83.
2. Ohnishi T, Rita H, Weiler D, Sur S, Sedgwick JB, Calhoun WJ, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late phase reaction. Am Rev Respir Dis 1993;147:901-7.
3. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77:527-37.
4. Aalbers R, Kauffman HF, Vrugt B, Smith M, Koëter GH, Timens W, et al. Bronchial lavage and bronchoalveolar lavage in allergen induced single early and dual asthmatic responders. Am Rev Respir Dis 1993;147:76-81.
5. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and GM-CSF mRNA at sites of allergic inflammation in asthma. J Clin Invest 1992;90:1414-24.
6. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denberg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
7. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993;147:1126-31.
8. Pin I, Freitag A, O'Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992;145:1265-9.
9. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994;93:1031-9.
10. Dickason RR, Huston MM, Huston DP. Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes. Cytokine 1994;6:647-56.
11. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and TNF-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.
12. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2 like bronchoalveolar T lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
13. Broide DH, Paine MM, Firestein GS. Eosinophils express IL-5 and GM-CSF mRNA at sites of allergic inflammation in asthma. J Clin Invest 1992;90:1414-24.
14. Gosset P, Tsicopoulos A, Wallaert B, Vannimenus C, Joseph M. Tonnel A-B, et al. Increased secretion of tumor necrosis factor α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991;88:561-71.
15. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor-α causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992;145:332-6.
16. Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-α alters human bronchial reactivity and induces inflammatory cell influx. Am Rev Respir Dis 1995;152:76-80.
17. Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, et al. Overlapping patterns of activation of human endothelial cells by IL-1, TNFα and immune Interferon. J Immunol 1986;137:1893-6.
18. Lassalle P, Gosset P, Delneste Y, Tsicopoulos A, Capron A, Joseph M, et al. Modulation of adhesion molecule expression on endothelial cells during the late asthmatic reaction: role of macrophage-derived TNFα. Clin Exp Immunol 1993;94:105-10.
19. Koike M, Tajkatsu K. IL-5 and its receptor. Int Arch Allergy Immunol 1994;104:1-9.
20. Broide DH, Firestein GS. Endobronchial allergen challenge in asthma: demonstration of cellular source of GM-CSF by in-situ hybridization. J Clin Invest 1991;88:1048-53.
21. Calhoun WJ, Jarjour NN, Gleich GJ, Stevens CA, Busse WW. Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993;147:1465-71.